NMDA antagonist MK801 recreates auditory electrophysiology disruption present in autism and other neurodevelopmental disorders

Behavioural Brain Research

Volumn 234, Issue 2, 2012, Pages 233-237

  Saunders, John A ^a,b   Gandal, Michael J ^a,b   Roberts, Timothy P ^b,c   Siegel, Steve J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Animal models; Autism; Electrophysiology; Endophenotype; NMDA receptor antagonist

Indexed keywords

BIOLOGICAL MARKER; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; AUTISM; CONTROLLED STUDY; ENDOPHENOTYPE; EVOKED AUDITORY RESPONSE; GAMMA RHYTHM; LATENT PERIOD; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANALYSIS OF VARIANCE; ANIMALS; AUTISTIC DISORDER; DEVELOPMENTAL DISABILITIES; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGICAL PHENOMENA; EVOKED POTENTIALS, AUDITORY; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICE; MICE, INBRED C57BL; REACTION TIME;

EID: 84864042396     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.06.032     Document Type: Article

References (25)

1. Edgar J.C., Keller J., Heller W., Miller GA Psychophysiology in research on psychopathology. Handbook of psychophysiology 2007, Cambridge University Press, New York. 3rd edition.
2. Amann L.C., Gandal M.J., Halene T.B., Ehrlichman R.S., White S.L., McCarren H.S., et al. Mouse behavioral endophenotypes for schizophrenia. Brain Research Bulletin 2010, 83:147-161.
3. Gandal M.J., Edgar J.C., Ehrlichman R.S., Mehta M., Roberts T.P., Siegel S.J. Validating gamma oscillations and delayed auditory responses as translational biomarkers of autism. Biological Psychiatry 2010, 68:1100-1106.
4. Gandal M.J., Edgar J.C., Klook K., Siegel S.J. Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia. Neuropharmacology 2011.
5. Bangash M.A., Park J.M., Melnikova T., Wang D., Jeon S.K., Lee D., et al. Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Cell 2011, 145:758-772.
6. Wu J., Zou H., Strong J.A., Yu J., Zhou X., Xie Q., et al. Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice. Psychopharmacology (Berlin) 2005, 177:256-263.
7. Zou H., Zhang C., Xie Q., Zhang M., Shi J., Jin M., et al. Low dose MK-801 reduces social investigation in mice. Pharmacology Biochemistry and Behavior 2008, 90:753-757.
8. Roberts T.P., Khan S.Y., Rey M., Monroe J.F., Cannon K., Blaskey L., et al. MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autism. Autism Research 2010, 3:8-18.
9. Sohal V.S., Zhang F., Yizhar O., Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 2009, 459:698-702.
10. Oram Cardy J.E., Flagg E.J., Roberts W., Roberts T.P. Auditory evoked fields predict language ability and impairment in children. International Journal of Psychophysiology 2008, 68:170-175.
11. Roberts T.P., Cannon K.M., Tavabi K., Blaskey L., Khan S.Y., Monroe J.F., et al. Auditory magnetic mismatch field latency: a biomarker for language impairment in autism. Biological Psychiatry 2011, 70:263-269.
12. Hanlon F.M., Miller G.A., Thoma R.J., Irwin J., Jones A., Moses S.N., et al. Distinct M50 and M100 auditory gating deficits in schizophrenia. Psychophysiology 2005, 42:417-427.
13. Mazhari S., Price G., Waters F., Dragovic M., Jablensky A. Evidence of abnormalities in mid-latency auditory evoked responses (MLAER) in cognitive subtypes of patients with schizophrenia. Psychiatry Research 2011, 187:317-323.
14. Saunders J.A., Gandal M.J., Siegel S.J. NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia. Neurobiology of Disease 2012, 46:93-100.
15. Gandal M.J., Ehrlichman R.S., Rudnick N.D., Siegel S.J. A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice. Neuroscience 2008, 157:95-104.
16. Siegel S.J., Connolly P., Liang Y., Lenox R.H., Gur R.E., Bilker W.B., et al. Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice. Neuropsychopharmacology 2003, 28:675-682.
17. Ehrlichman R.S., Gandal M.J., Maxwell C.R., Lazarewicz M.T., Finkel L.H., Contreras D., et al. N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia. Neuroscience 2009, 158:705-712.
18. Umbricht D., Vyssotky D., Latanov A., Nitsch R., Brambilla R., D'Adamo P., et al. Midlatency auditory event-related potentials in mice: comparison to midlatency auditory ERPs in humans. Brain Research 2004, 1019:189-200.
19. Delorme A., Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. Journal of Neuroscience Methods 2004, 134:9-21.
20. Lushchekina E.A., Podreznaia E.D., Lushchekin V.S., Strelets V.B. Comparative EEG study in normal and autistic children. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova 2010, 60:657-666.
21. Burket J.A., Cannon W.R., Jacome L.F., Deutsch S.I. MK-801, a noncompetitive NMDA receptor antagonist, elicits circling behavior in the genetically inbred Balb/c mouse strain. Brain Research Bulletin 2010, 83:337-339.
22. Creten C., van der Zwaan S., Blankespoor R.J., Maatkamp A., Nicolai J., van Os J., et al. Late onset autism and anti-NMDA-receptor encephalitis. Lancet 2011, 378:98.
23. Ninan I., Kulkarni S.K. 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion. European Journal of Pharmacology 1998, 358:111-116.
24. Ralph-Williams R.J., Lehmann-Masten V., Otero-Corchon V., Low M.J., Geyer M.A. Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. Journal of Neuroscience 2002, 22:9604-9611.
25. de Oliveira R.V., Dall'Igna O.P., Tort A.B., Schuh J.F., Neto P.F., Santos Gomes M.W., et al. Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice. Behavioural Pharmacology 2005, 16:79-84.